Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 19, 2024 - Issue
Submit an article Journal homepage
64
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Inhibitory Effect of P22077 on Airway Inflammation in Rats with COPD and Its Mechanism

Di Zeng1 Department of General Practice, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-0240-280X
ORCID Icon,
Wenbo Zhang2 Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, People’s Republic of China
,
Xiaoju Chen3 Clinical Medical College, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, 610081, People’s Republic of ChinaCorrespondence[email protected]
,
Guochun Ou4 Department of Respiratory and Critical Care Medicine, Suining Central Hospital, Suining, Sichuan, 629000, People’s Republic of China
,
Yuewei Huang2 Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, People’s Republic of China
&
Chengxiu Yu2 Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, People’s Republic of China
Pages 779-788 | Received 24 Nov 2023, Accepted 13 Mar 2024, Published online: 19 Mar 2024

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2023 Report. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed 18 March 2024.
  • World Health Organization. Projections of mortality and causes of death, 2017-2060 【EB/OL】 2018.
  • Zhang X, Xu A, Lv J, et al. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases. Eur J Med Chem. 2020;185:111822. doi:10.1016/j.ejmech.2019.111822
  • Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677–687. doi:10.1038/nm.3893
  • Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13(6):397–411. doi:10.1038/nri3452
  • Yang J, Liu Z, Xiao TS. Post-translational regulation of inflammasomes. Cell Mol Immunol. 2017;14(1):65–79. doi:10.1038/cmi.2016.29
  • Juliana C, Fernandes-Alnemri T, Kang S, Farias A, Qin F, Alnemri ES. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem. 2012;287(43):36617–36622. doi:10.1074/jbc.M112.407130
  • Zeng M, Zhang X, Xing W, Wang Q, Liang G, He Z. Cigarette smoke extract mediates cell premature senescence in chronic obstructive pulmonary disease patients by up-regulating USP7 to activate p300-p53/p21 pathway. Toxicol Lett. 2022;359:31–45. doi:10.1016/j.toxlet.2022.01.017
  • Palazon-Riquelme P, Worboys JD, Green J, et al. USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. EMBO Rep. 2018;19(10). doi:10.15252/embr.201744766
  • Cui Y, Luo L, Zeng Z, et al. MFG-E8 stabilized by deubiquitinase USP14 suppresses cigarette smoke-induced ferroptosis in bronchial epithelial cells. Cell Death Dis. 2023;14(1):2. doi:10.1038/s41419-022-05455-8
  • Juliana C, Fernandes-Alnemri T, Wu J, et al. Anti-inflammatory compounds parthenolide and bay 11–7082 are direct inhibitors of the inflammasome. J Biol Chem. 2010;285(13):9792–9802. doi:10.1074/jbc.M109.082305
  • Song X, Wang C, Bai C. Establishment of rat chronic obstructive pulmonary disease model: a comparison between exposure to cigarette smoke alone and in combination with intra-tracheal injection of lipopolysaccharide. Former Acad J Sec Mil Med Univers. 2010;31(03):246–249. doi:10.3724/SP.J.1008.2010.00246
  • Kim RY, Pinkerton JW, Gibson PG, Cooper MA, Horvat JC, Hansbro PM. Inflammasomes in COPD and neutrophilic asthma. Thorax. 2015;70(12):1199–1201. doi:10.1136/thoraxjnl-2014-206736
  • Franklin BS, Bossaller L, De Nardo D, et al. The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat Immunol. 2014;15(8):727–737. doi:10.1038/ni.2913
  • Nachmias N, Langier S, Brzezinski RY, et al. NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. PLoS One. 2019;14(5):e214622. doi:10.1371/journal.pone.0214622
  • Faner R, Sobradillo P, Noguera A, et al. The inflammasome pathway in stable COPD and acute exacerbations. ERJ Open Res. 2016;2(3):00002–2016. doi:10.1183/23120541.00002-2016
  • Song H, Zhao C, Yu Z, et al. UAF1 deubiquitinase complexes facilitate NLRP3 inflammasome activation by promoting NLRP3 expression. Nat Commun. 2020;11(1):6042. doi:10.1038/s41467-020-19939-8
  • Mitxitorena I, Somma D, Mitchell JP, et al. The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-kB subunits. J Biol Chem. 2020;295(33):11754–11763. doi:10.1074/jbc.RA120.014113
  • Zhao XB, Ji FY, Li HR, et al. P22077 inhibits LPS-induced inflammatory response by promoting K48-linked ubiquitination and degradation of TRAF6. Aging. 2020;12(11):10969–10982. doi:10.18632/aging.103309
  • Liu G, Liu Q, Yan B, Zhu Z, Xu Y. USP7 inhibition alleviates H(2)O(2)-induced injury in chondrocytes via inhibiting NOX4/NLRP3 pathway. Front Pharmacol. 2020;11:617270. doi:10.3389/fphar.2020.617270

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.